(June 6, 2016, 12:23 PM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court on June 6 denied a motion by GlaxoSmithKline LLC (GSK) to review a trial court’s refusal to dismiss a Racketeer Influenced and Corrupt Organizations Act case brought by third-party payers involving the drug manufacturer’s marketing of the diabetes drug Avandia (GlaxoSmithKline LLC v. Allied Services Division Welfare Fund, et al., No. 15-1078, U.S. Sup.)....